Skip to main content

Table 3 Information available at admission predictivefor ≥ 1 organ failure within one day

From: Age-related differences in symptoms, diagnosis and prognosis of bacteremia

 

Patients without organ failure(342 patients;%within this group)

Patients with organ failure(290 patients;%within this group)

Bivariate analyses OR(95% CI)

Multivariate analysis; full maineffects’model*OR(95%CI)

Age ≥ 65 years

204 (59.6)

215 (74.1)

1.94 (1.38-2.73)

1.65 (1.09 - 2.49)

Male gender

137 (40.1)

135 (46.6)

1.30 (0.95 – 1.79)

 

No. of comorbid illnesses

-

-

1.41 (1.23-1.61)

1.19 (1.02 - 1.40)

Corticosteroid on a daily basis1

8 (2.4)

23 (8.0)

3.55 (1.56 – 8.05)

2.75 (1.10 - 6.89)

Cytostatic treatment within last 14 days

1 (0.3)

6 (2.1)

7.10 (0.85 - 59.34)

 

Immunosuppressive treatment

1 (0.3)

5 (1.7)

5.90 (0.69 - 50.77)

 

Number of symptoms ≥ 5

35 (10.2)

41 (14.2)

1.45 (0.90 – 2.35)

 

“Classical symptoms”2 ≥ 3

141 (41.3)

97 (33.7)

0.72 (0.52 - 0.99)

0.67 (0.45 - 0.99)

“Atypical symptoms”3 ≥ 1

151 (44.2)

169 (58.3)

1.77 (1.29 - 2.42)

 

Decline in general health (as described in the emergencydepartment)

112 (32.8)

166 (57.2)

2.74 (1.98 - 3.79)

2.28 (1.58 - 3.27)

Heart rate > 90 beats per minute

197 (58.5)

203 (70.7)

1.72 (1.23 - 2.40)

1.50 (1.02 - 2.20)

Fever (≥ 38.5°C)

229 (68.4)

178 (62.2)

0.76 (0.55 - 1.06)

 

Hypothermia (< 36°C)

4 (1.2)

6 (2.1)

1.77 (0.50 - 6.35)

 

Tachypnoe and/or hyperventilation

78 (22.8)

167 (57.6)

4.60 (3.26 - 6.48)

3.86 (2.64 - 5.66)

Leukocytosis (≥ 15000/μl)

145 (42.4)

118 (40.7)

0.93 (0.68 - 1.28)

 

Leukopenia (< 3000/μl)

6 (1.8)

31 (10.7)

6.70 (2.76 - 16.31)

4.16 (1.59 - 10.91)

CRP ≥ 80 mg/L

253 (74.0)

233 (80.3)

1.44 (0.99 - 2.10)

 

CRP ≥ 200 mg/L

157 (45.9)

153 (52.8)

1.32 (0.96 -1.80)

 

New-onset atrial fibrillation

35 (10.4)

64 (22.1)

2.45 (1.57 - 3.82)

 
  1. OR = odds ratio, CI = confidence interval.1Equivalent toprednisolone ≥ 10 mg per day,2“Classical symptoms”: fever/chills, localizedpain, nausea/vomiting, diarrhea, cough, dyspnea, expectoration, urgency,painful voiding, hematuria, skin rash and coma/seizures,3“atypical symptoms”: Malaise, falls, dizziness,syncope, unsteadiness, immobility, acute incontinence of urine or feces,paresis/speaking difficulties, acute confusional state. *Analyses ofinteractions indicated that high age significantly reduced the effect oftachypnea and/or hyperventilation and the effect of number of comorbidillnesses on early organ failure (results not shown).